Known targets — ChEMBL curated mechanism
ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3CHRM1CHRM2CHRM3CHRM4ESR1ESR2GABRA1GABRB1GABRG2GBA1HRH1HTR1DHTR2AOPRD1OPRK1OPRM1SLC6A2SLC6A3TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8rplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Cadaverine Tartrate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 known ✓ | P14867 | 2/20 | 0.42 |
| ▸ | GBA1 known ✓ | P04062 | 1/20 | 0.39 |
| ▸ | GABRB1 known ✓ | P18505 | 1/20 | 0.35 |
| ▸ | GABRG2 known ✓ | P18507 | 1/20 | 0.35 |
| ▸ | SLC6A1 | P30531 | 4/20 | 0.42 |
| ▸ | GABRA5 | P31644 | 3/20 | 0.42 |
| ▸ | GABRB2 | P47870 | 3/20 | 0.42 |
| ▸ | SLC6A11 | P48066 | 3/20 | 0.42 |
| ▸ | SLC6A13 | Q9NSD5 | 3/20 | 0.42 |
| ▸ | SLC6A12 | P48065 | 2/20 | 0.42 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.42 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 3/20 | 0.40 |
| ▸ | GABRP | O00591 | 1/20 | 0.35 |
| ▸ | GABRD | O14764 | 1/20 | 0.35 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.35 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.35 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.35 |
| ▸ | GABRE | P78334 | 1/20 | 0.35 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cadaverine Tartrate SCHEMBL28104526 | 0.89 | SLC6A1 (0.46) | SLC6A1GABRA5GABRB2SLC6A11SLC6A13 | |
| Cadaverine Tartrate SCHEMBL29035526 | 0.88 | TSHR (0.43) | SLC6A1GABRA5GABRB2SLC6A11SLC6A13 | |
| Acetic Acid SCHEMBL28792105 | 0.81 | SLC6A1 (0.47) | SLC6A1GABRA5GABRB2SLC6A11SLC6A13 | |
| Valine SCHEMBL16597283 | 0.78 | SLC7A5 (0.52) | SLC6A1GABRA5GABRB2SLC6A11SLC6A13 | |
| Fumaric Acid SCHEMBL5669347 | 0.78 | SLC6A1 (0.44) | SLC6A1GABRA5GABRB2SLC6A11SLC6A13 | |
| Fumaric Acid SCHEMBL5669341 | 0.78 | SLC6A1 (0.44) | SLC6A1GABRA5GABRB2SLC6A11SLC6A13 | |
| Succinic Acid SCHEMBL28131963 | 0.78 | SLC6A1 (0.53) | SLC6A1GABRA5GABRB2SLC6A11SLC6A13 | |
| SCHEMBL203460 | 0.78 | — | — | |
| SCHEMBL336177 | 0.78 | — | — | |
| SCHEMBL242920 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1638934-A1 | 3-AMINOPYRROLIDINES AS INHIBITORS OF MONOAMINE UPTAKE | ELI LILLY AND COMPANY (US) | 2006-03-29 | — | — | EP | disclosed |
| WO-2005000811-A1 | 3-AMINOPYRROLIDINES AS INHIBITORS OF MONOAMINE UPTAKE | ELI LILLY AND COMPANY (US) | 2005-01-06 | — | — | WO | disclosed |